Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 10, No. 6, 2000   

Free Abstract     Article (Fulltext)     Article (PDF 128 KB)     

Original Paper

Diazepam Treatment to Increase the Cerebral GABAergic Activity in Acute Stroke: A Feasibility Study in 104 Patients
J. Loddera, G.J. Luijckxc, L. van Raaka, F. Kesselsb

aDepartment of Neurology and
bClinical Research Unit, University Hospital, Maastricht, and
cDepartment of Neurology, Maasland Hospital, Sittard, The Netherlands

Address of Corresponding Author

Cerebrovasc Dis 2000;10:437-440 (DOI: 10.1159/000016104)


 goto top of page Key Words

  • Diazepam
  • Acute stroke
  • Neuroprotection
  • GABAergic activity

 goto top of page Abstract

In preparation of a trial on the neuroprotective effect of GABAergic activation by a benzodiazepine, we performed a feasibility study in 104 patients with acute (less than 24 h) stroke. 5 mg diazepam twice daily for 5 days (n = 44) was well tolerated, feasible, and appeared to be safe. Testing a dose of 10 mg twice daily for 5 days (n = 17) was stopped early because of drowsiness around day 5, interfering with regular patient care. A dose of 10 mg twice daily for 3 days was well tolerated, despite reported drowsiness in 12 of 43 patients. First-dose application by rectiole was feasible in 97% of the 104 patients. No blood pressure drop or respiratory arrest or insufficiency were detected, whereas the 2-week case fatality rate was similar to that of controls matched for age, sex, and stroke severity. We conclude that testing the GABAergic activity during the acute phase of stroke by 10 mg diazepam twice daily for 3 days is well tolerated and practically feasible, and it does not subject patients to an increased risk of potential serious adverse effects. Preparations for a large randomized trial are in a final stage.

Copyright © 2000 S. Karger AG, Basel


 goto top of page Author Contacts

J. Lodder, MD, PhD
Department of Neurology
University Hospital, PO Box 5800
NL-6202 AZ Maastricht (The Netherlands)
Tel. +31 43 3877060, Fax +31 43 3877055, E-Mail jlod@sneu.azm.nl


 goto top of page Article Information

Accepted: February 22, 2000
Number of Print Pages : 4
Number of Figures : 0, Number of Tables : 0, Number of References : 20

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Search in this issue




This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

Case Reports in Neurology


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2009 S. Karger AG, Basel